Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Vitamin K2 and Reduced Dephosphorylated-Uncarboxylated MGP Level

Doses used in studies

mcg/day: 360 (median 360, IQR 360–360) — 1 study

Time to effect

Median: 4 weeks · IQR 4 weeks–4 weeks · Range 4 weeks–4 weeks — Reported in 1 of 1 study

1 of 1 paper

High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K2, A pre-post intervention clinical trial.
- 2017-06-07
- Clinical Trial
- BMC nephrology 18(1)
- - Mabel Aoun
  - Maha Makki
  - Hiba Azar
  - Hiam Matta
  - Dania Nehme Chelala
- PubMed: 28592319
- DOI: 10.1186/s12882-017-0609-3
1 Insight on
- Reduced Dephosphorylated-Uncarboxylated MGP Level
- Moderate evidence
- Clinical
The average drop of dp-ucMGP at 4 weeks of treatment was found to be 86%
Effect
Beneficial
Effect size
Large
Significant
Yes
Dose
360 μg/day